drugset / Trial / NCT00952393
Nicotinic Receptors and Schizophrenia
NaSingle-groupOpen-labelTreatment
Summary
The study determines if a new preparation of a drug designed to treat schizophrenia is more slowly released into the body.
Timeline
- Start
- 2010-01
- Primary completion
- 2014-10
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 3-2,4 dimethoxy-benzilidene anabaseine | Unknown | 150 mg | — |
| Subject | 3-2,4 dimethoxy-benzilidene anabaseine | Unknown | 300 mg | — |